You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨萊美藥業漲近9% 四部門聯合發文打造一批原料藥集中生產基地
格隆匯 01-03 13:45
格隆匯1月3日丨萊美藥業(300006.SZ)漲近9%,報6.11元,總市值49.6億元。工信部等四部門近日聯合發佈《推動原料藥產業綠色發展的指導意見》,到2025年,採用綠色工藝生產的原料藥比重進一步提高,高端特色原料藥市場份額顯著提升;產業佈局更加優化,原料藥基本實現園區化生產,打造一批原料藥集中生產基地;清潔生產水平明顯提高,單位工業增加值能耗、二氧化碳排放量、用水量以及二氧化硫、氮氧化物、揮發性有機物等主要污染物排放強度逐步下降。機構認為,相關部門將充分利用現有資金渠道,支持建設技術創新平台、推行生產技術改造、開發綠色新產品。創新金融服務產品和服務方式,推動發展綠色信貸業務,加大原料藥綠色生產金融支持力度。對臨牀急需、市場短缺的原料藥予以優先審評審批。萊美藥業主要從事喹諾酮類抗感染藥物和一些專科特色用藥的研發、產銷。產品主要包括抗感染藥,抗腫瘤藥和腸外營養藥。其中,淋巴靶向治療的納米藥物技術處於國際領先水平。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account